Influence of chronic pentobarbital or morphine treatment on the incorporation of 32Pi and [3H]choline into rat synaptic plasma membranes

Robert J. Hitzemann; Horace H. Loh

doi:10.1016/0006-2952(77)90250-7

Influence of chronic pentobarbital or morphine treatment on the incorporation of ³²P_i and [³H]choline into rat synaptic plasma membranes

Robert J. Hitzemann, Horace H. Loh

Pharmacology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	1087-1089
Number of pages	3
Journal	Biochemical Pharmacology
Volume	26
Issue number	11
DOIs	https://doi.org/10.1016/0006-2952(77)90250-7
State	Published - Jun 1 1977

Bibliographical note

Funding Information:
All incubations were carried out in 25-ml Erlenmeyer flasks containing 2.5 ml of tubular suspension (approximately 12mg protein) in a phosphate buffer (pH 7.4) at 37”. The incubation was started by addition of tubules to the medium which had been equilibrated at 37’ under IOO~,Õ2 for 5 min. Ethanolic solutions of verapamil and D-600 (kindly provided by Knoll Pharmaceutical Co.) were * This investigation was supported by grants from The Health Research Council of the City of New York (U-2326) and the New York Diabetes Association.

Funding Information:
Aclinoa,l~~~grttlse ,IIT he authors acknowledge the editorial and typing assistance of Lois Trapp and the technicat assistance of Barbara Hitzemann. This study was supported in part by USPHS Grant DA-00564. H. H. L. is a recipient of an NIMH Research Scientist Career Development Award. K2-DA-70554.

Access

10.1016/0006-2952(77)90250-7

OpenUrl availability

Full text

Cite this

@article{cd27609fd8534940a46e133b2c08c43f,

title = "Influence of chronic pentobarbital or morphine treatment on the incorporation of 32Pi and [3H]choline into rat synaptic plasma membranes",

author = "Hitzemann, {Robert J.} and Loh, {Horace H.}",

note = "Funding Information: All incubations were carried out in 25-ml Erlenmeyer flasks containing 2.5 ml of tubular suspension (approximately 12mg protein) in a phosphate buffer (pH 7.4) at 37”. The incubation was started by addition of tubules to the medium which had been equilibrated at 37{\textquoteright} under IOO~,{\~O}2 for 5 min. Ethanolic solutions of verapamil and D-600 (kindly provided by Knoll Pharmaceutical Co.) were * This investigation was supported by grants from The Health Research Council of the City of New York (U-2326) and the New York Diabetes Association. Funding Information: Aclinoa,l~~~grttlse ,IIT he authors acknowledge the editorial and typing assistance of Lois Trapp and the technicat assistance of Barbara Hitzemann. This study was supported in part by USPHS Grant DA-00564. H. H. L. is a recipient of an NIMH Research Scientist Career Development Award. K2-DA-70554.",

year = "1977",

month = jun,

day = "1",

doi = "10.1016/0006-2952(77)90250-7",

language = "English (US)",

volume = "26",

pages = "1087--1089",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Influence of chronic pentobarbital or morphine treatment on the incorporation of 32Pi and [3H]choline into rat synaptic plasma membranes

AU - Hitzemann, Robert J.

AU - Loh, Horace H.

N1 - Funding Information: All incubations were carried out in 25-ml Erlenmeyer flasks containing 2.5 ml of tubular suspension (approximately 12mg protein) in a phosphate buffer (pH 7.4) at 37”. The incubation was started by addition of tubules to the medium which had been equilibrated at 37’ under IOO~,Õ2 for 5 min. Ethanolic solutions of verapamil and D-600 (kindly provided by Knoll Pharmaceutical Co.) were * This investigation was supported by grants from The Health Research Council of the City of New York (U-2326) and the New York Diabetes Association. Funding Information: Aclinoa,l~~~grttlse ,IIT he authors acknowledge the editorial and typing assistance of Lois Trapp and the technicat assistance of Barbara Hitzemann. This study was supported in part by USPHS Grant DA-00564. H. H. L. is a recipient of an NIMH Research Scientist Career Development Award. K2-DA-70554.

PY - 1977/6/1

Y1 - 1977/6/1

UR - http://www.scopus.com/inward/record.url?scp=0017380429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017380429&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(77)90250-7

DO - 10.1016/0006-2952(77)90250-7

M3 - Article

C2 - 880262

AN - SCOPUS:0017380429

SN - 0006-2952

VL - 26

SP - 1087

EP - 1089

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 11

ER -